SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹15,119 Cr | ₹13,752 Cr | ₹11,088 Cr | ₹9,408 Cr | ₹4,481 Cr |
| Adjustment | ₹882 Cr | ₹1,120 Cr | ₹1,554 Cr | ₹2,723 Cr | ₹1,975 Cr |
| Changes In working Capital | ₹-1,268 Cr | ₹-324 Cr | ₹1,062 Cr | ₹-5,662 Cr | ₹1,559 Cr |
| Cash Flow after changes in Working Capital | ₹14,733 Cr | ₹14,549 Cr | ₹13,704 Cr | ₹6,469 Cr | ₹8,015 Cr |
| Cash Flow from Operating Activities | ₹12,419 Cr | ₹14,072 Cr | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr |
| Cash Flow from Investing Activities | ₹-11,344 Cr | ₹-5,306 Cr | ₹-690 Cr | ₹-7,944 Cr | ₹-5,725 Cr |
| Cash Flow from Financing Activities | ₹-2,513 Cr | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr |
| Net Cash Inflow / Outflow | ₹-1,437 Cr | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr |
| Opening Cash & Cash Equivalents | ₹10,269 Cr | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr | ₹6,273 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹163 Cr | ₹-0.03 Cr | ₹1.29 Cr | ₹567 Cr | ₹41 Cr |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹776 Cr | ₹123 Cr | ₹-74 Cr | ₹157 Cr | ₹127 Cr |
| Closing Cash & Cash Equivalent | ₹9,771 Cr | ₹10,269 Cr | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr |
Compare Cashflow Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,623.6 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| MANKIND PHARMA | ₹101,267.0 Cr | -4.9% | -3.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.6% |
2.4% |
14.6% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses